Jon compared Neuren to the Reata deal in the PHS webinar when he said 'We hope we have got more than that' In my opinion, when PH is added to PMS along with the undisclosed indications I maintain it is a valid comparison to say despite the Reata drug already being approved.
A couple of posters were talking a week or so ago about how long things feel like they are taking. I feel like the word 'eternity' is apt but it continues to be a great lesson in patience.
Fingers crossed.
Share Price, page-10946
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.56 |
Change
-0.400(2.67%) |
Mkt cap ! $1.860B | |||
| Open | High | Low | Value | Volume |
| $14.96 | $15.00 | $14.18 | $7.303M | 503.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30783 | $14.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.60 | 1006 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |